May 26 (UPI) -- President Donald Trump and the Centers for Medicare and Medicaid Services on Tuesday unveiled a plan that will cap costs on insulin for Medicare patients.
The plan will cap the cost of insulin copays for more than 1,750 standalone Medicare Part D prescription drug plans and Medicare Advantage plans for seniors at $35 for a month's supply for the 2021 plan year.